Previous Article | Next Article 
Journal of Virology, February 1999, p. 1213-1218, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Radiation-Resistant and Radiation-Sensitive Forms
of Host Resistance to Polyomavirus
John P.
Carroll,1
John S.
Fung,1
Roderick T.
Bronson,2
Enal
Razvi, and
Thomas L.
Benjamin1,*
Department of Pathology, Harvard Medical
School, Boston, Massachusetts 02115,1 and
Department of Human Nutrition Research Center, Tufts
University, Boston, Massachusetts 021112
Received 15 July 1998/Accepted 27 October 1998
 |
ABSTRACT |
Newborn mice of several inbred strains develop few or no tumors
following inoculation with highly tumorigenic strains of polyomavirus. Here we show that such resistant strains can be divided into two groups
based on the responses of adult mice to radiation followed by virus
inoculation. Most strains show a radiation-sensitive form of resistance
(Rr-s) and develop tumors following radiation and virus
challenge. This type of resistance has previously been recognized as
immunological, based on T-cell responses against virus-encoded
neoantigen(s) expressed in tumor cells. Other strains exhibit a
radiation-resistant form of resistance (Rr-r) and fail to
develop tumors when treated in the same manner. Three additional
properties of Rr-r mice distinguish them from
Rr-s mice: (i) survival of newborns following inoculation
with a highly virulent and usually lethal strain of virus, (ii)
resistance to virus spread in newborns inoculated with either
tumorigenic or virulent virus strains, and (iii) dominant or
semidominant transmission of resistance in crosses with a highly
susceptible strain. The Rr-r phenotype reflects a
constitutive nonimmunological type of resistance that is targeted to
the virus and blocks its dissemination.
 |
INTRODUCTION |
Studies of the genetics of the mouse
in relation to infections by the oncogenic murine polyomavirus promise
to reveal multiple factors with diverse modes of action. Variations in
susceptibility to tumor induction by polyomavirus among inbred mouse
strains have been noted (8, 11, 14; data not shown).
Much of this variation reflects differences in the abilities of
different strains of mice to generate virus-specific anti-tumor immune
responses, resulting in variable overall tumor frequencies. In
addition, some strains exhibit resistance to tumor development in
specific target tissues while being susceptible at other sites,
suggesting the existence of nonimmunological
mechanism(s). The host genetic background can influence
events as diverse as the early events of virus replication and spread
as a necessary prelude to the induction of a broad array of tumors and
late events affecting the likelihood of metastases of specific tumor
types. The identity and mechanisms of action of most of these genes
remain unknown. Here we describe two contrasting forms of host
resistance, one that prevents tumor induction by targeting the virus
and preventing its spread and one that acts downstream of virus spread,
targeting incipient tumors for immunological rejection.
A survey of over 30 inbred mouse strains has uncovered several
strains which show a total or near-total absence of tumors or
development of a restricted spectrum of tumor types following inoculation of newborn animals with highly tumorigenic strains of
virus. These resistant strains can be divided into two groups based on
the responses of adult mice to ionizing radiation followed by virus
inoculation. The use of radiation is necessary because newborn mice of
even the most susceptible strains are known to acquire resistance as
adults (16). Maturation of immune mechanisms is generally
regarded as the basis for this acquisition of resistance, although
other mechanisms may also be involved.
Most resistant strains show a radiation-sensitive form of resistance,
designated Rr-s, indicated by the development of tumors in
a high proportion of treated animals. Earlier studies have established
the Rr-s phenotype as the norm of host resistance, mediated
by cellular immune responses to polyomavirus-induced tumors
(1, 15, 16, 24). MHC (major histocompatibility complex) type
is a major determinant of this kind of resistance (11). The
present study reveals a second form of host resistance, based on the
observation that mice of certain strains fail to develop tumors
following radiation and virus challenge. This radiation-resistant form
of resistance, designated Rr-r, operates through a
nonimmunological mechanism that blocks virus dissemination in the
intact host.
 |
MATERIALS AND METHODS |
C3H/BiDa mice were obtained initially from Clarence Reeder
(National Cancer Institute, Fredrick Cancer Research and Development Center, Fredrick, Md.). C57BR/cdJ, MA/MyJ, CE/J, and C57BL/6J mice were
obtained from the Jackson Laboratory, Bar Harbor, Maine. All mice were
maintained in our virus-free breeding colony. F1 crosses
were performed reciprocally.
Mice younger than 24 h of age were inoculated intraperitoneally
with 0.05 ml of A2, A2+ (10), or LID (2, 3)
polyomavirus containing approximately 2 × 105 to
1 × 106 PFU. Four- to six-week-old mice received
between 500 and 900 rads of
radiation in a Gammacell 40 (Atomic
Energy of Canada, Ltd., Ottawa) and 24 h later were inoculated
intraperitoneally with virus. Mice were inspected twice weekly and
necropsied when moribund or at 6 to 12 months of age. Tumors and
tissues were fixed in Bouins' solution and embedded in paraffin, and
sections were stained with Harris' hematoxylin and eosin as previously described (5, 13). All gross tumors other than those of bone were confirmed by microscopic examination.
Whole mouse section hybridization was performed as previously described
(6, 7). Briefly, mice inoculated at birth were sacrificed at
10 days and frozen in Tissue-Tek embedding medium (OCT 4583).
Parasagittal sections were transferred to nitrocellulose membranes and
hybridized to 35S-labelled nick-translated polyomavirus
DNA, and the hybridization signal was visualized by autoradiography.
Tests for innate immunity (NK cells and antiviral interferons) were
carried out as described previously (25; see text).
 |
RESULTS |
Patterns of susceptibility and resistance to tumor induction by
polyomavirus.
Three patterns of host responses are apparent based
on comparisons of tumor development in newborn versus irradiated adult mice (Table 1) as follows:
(i) Susceptible strains (S).
C3H/BiDa is one of several inbred
strains known to be highly susceptible to the oncogenic effects of
polyomavirus. When inoculated within 24 h of birth with an
appropriate strain of virus, these mice develop multiple tumors in
frequencies approaching 100% within a period of 3 to 4 months (5,
13). Susceptibility in these strains is based in large part on a
common MHC background (H2k) coupled with an
endogenous superantigen encoded by a particular mouse mammary
tumor provirus (Mtv-7 sag). In the H-2k
background, the Mtv-7 superantigen effectively deletes precursors of polyomavirus-specific cytotoxic T lymphocytes, rendering
these mice unable to reject polyomavirus-induced tumors (17,
18).
Interestingly, mice of these highly susceptible strains develop
resistance as adults. In the present study, for example, none
of
16 adult C3H/BiDa mice developed tumors when inoculated with
doses of
virus that were the same or higher than those given to
newborns.
This resistance can be overcome by sublethal doses of
radiation prior
to virus inoculation. Radiation-sensitive resistance
in adult mice
suggests that immune mechanisms are lacking or not
fully developed in
the
newborn.
(ii) Radiation-sensitive resistant strains (Rr-s).
Many strains of mice show inoculated as newborns partial or complete
resistance to tumor induction. Earlier studies have shown that normally
resistant strains such as C57BL/6J can be rendered susceptible
following immune suppression by a variety of mechanisms, such as
radiation or neonatal thymectomy or administration of antilymphocyte
serum (1, 15, 16, 24).
This type of resistance is illustrated with two other highly resistant
strains, C57BR/cdJ and MOLD/RkJ. The phenotype of these
R
r-s mice is consistent with immunological resistance based
not only
on their radiation susceptibility as adults but also on the
known
interaction of MHC and endogenous superantigen as codeterminants
of susceptibility in this system (
17). Thus, C57BL/6J and
MOLD/RkJ
bear a type other than
H-2
k at the MHC
locus, and C57BR/cdJ, though
H-2
k, lacks the
Mtv-7 provirus (
17). Although radiation overcomes
the
resistance in adult mice of both S and R
r-s strains, the
tumor profiles are different. The adult irradiated
C3H/BiDa (S) mice
developed no fibrosarcomas but otherwise showed
a broad range of tumors
similar to the range seen with newborn
mice. Adult irradiated C57BR/cdJ
(R
r-s) mice all developed salivary gland tumors but showed
much-reduced
frequencies of other tumor types and none in either kidney
or
bone. The greater frequency of tumors in adult irradiated C3H/BiDa
mice may reflect the presence of the dominant susceptibility gene
Mtv
7-sag in this strain (
17).
(iii) Radiation-resistant resistant strains
(Rr-r).
Not all neonatally-resistant mice develop a
radiation-sensitive form of resistance as adults as is clearly
illustrated with mice of the MA/MyJ strain. Adult mice of this strain
maintain complete resistance to tumor induction by polyomavirus, even
when they are given immunosuppressive doses (up to 900 rads) of radiation.
CE/J mice show limited susceptibility as newborns but are nevertheless
considered to have an R
r-r phenotype. The 10 of 28 neonatally infected CE/J mice that developed
tumors developed only
single fibrosarcomas after an unusually
long latent period; no other
tumors typical of the polyomavirus
tumor profile were seen in these
animals. Most importantly, CE/J
mice showed complete resistance to
tumor development as adults
following irradiation and virus
challenge.
MA/MyJ mice are resistant to the virulent LID virus strain.
LID is a virulent strain of polyomavirus which spreads rapidly in
newborn mice, inducing widespread cytolytic damage, particularly in the
kidney and brain (2, 3). Newborn mice were inoculated intraperitoneally with 106 PFU of the LID strain, as
previously described (2). Following are data on the
fractions of animals surviving up to 30 days. All 20 newborn C3H/BiDa
mice inoculated with this virus died within 2 weeks. All of the mice of
the Rr-s strains C57BR/cdJ (n = 20) and
C57BL/6J (n = 21) were also killed by LID. Some of
these mice survived for up to 3 weeks but uniformly succumbed, with the
same pattern of virus spread and cytolytic damage as that seen in
C3H/BiDa mice. The slightly extended average survival time of
Rr-s compared to that of susceptible mice may reflect a
degree of viral clearance by polyomavirus-specific cytotoxic T
lymphocytes present in the former but absent in the latter strains
(17, 18).
In contrast to R
r-s mice, 25 of 25 newborn MA/MyJ mice
survived following inoculation with LID. Although none of these mice
succumbed
to the acute lytic effects of LID, about 60% developed
tumors.
Such tumors developed late and occurred only in bone and
kidney.
CE/J mice, unlike MA/MyJ mice, succumbed to LID infection as
newborns.
The limited tumor profile induced in MA/MyJ mice by LID is similar to
that induced in highly susceptible C3H/BiDa mice by
the low tumor virus
strain RA, which replicates poorly in these
mice (
5). A
single amino acid substitution in the outer capsid
protein VP1
underlies the important biological differences between
high and low
tumor virus strains (
6,
9,
12). This difference
also
dictates the viruses' ability to discriminate among different
linkages
of sialic acid on the cell surface and their ability
to spread in the
intact host (
22,
23). The virulence determinant
in LID
likewise maps to a single amino acid substitution in VP1;
in this case,
the substitution results in a lower affinity of
binding by the virus to
its sialic acid receptor (
2).
These results correlating pathogenicity of the virus to its
interactions with cell receptors suggest that MA/MyJ mice may
have a
mechanism which curtails virus spread, acting perhaps at
the level of
virus-cell binding or possibly at the level of entry
or release of
virus from infected cells. Such a mechanism would
be consistent with
the findings noted above, viz., diminution
of pathogenicity of both
tumorigenic and virulent strains of polyomavirus
in MA/MyJ mice. Since
R
r-s mice succumb to disseminated lytic infection by LID,
they would
be expected to lack such a mechanism preventing virus
spread.
Newborn MA/MyJ mice are highly resistant to virus spread.
To
test these predictions, newborn mice of each prototype strain were
inoculated with either the high tumor (A2) or virulent (LID) strain of
virus, and the degree of virus spread was determined by whole mouse
section hybridization at 10 days (Fig.
1). The results show that MA/MyJ
(Rr-r) mice are highly resistant to the spread of both
virus strains (Fig. 1A and D). C57BR/cdJ (Rr-s) mice, on
the other hand, are susceptible to disseminated infection by both
viruses (Fig. 1B and E), showing degrees of spread only slightly less
than those seen in C3H/BiDa (S) mice (Fig. 1C and F).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
Whole mouse section hybridization. MA/MyJ (A and D),
C57BR/cdJ (B and E), and C3H/BiDa (C and F) mice were inoculated at <1
day old with A2 (A to C) or LID (D to F) virus and sacrificed at 10 days. See text.
|
|
Immunoperoxidase staining for VP1 in kidney sections of these mice gave
indications of virus spread consistent with the results
of
hybridization. MA/MyJ mice showed strong systemic resistance
to virus
spread relative to both C57BR/cdJ and C3H/BiDa mice,
regardless of the
route of virus inoculation (intraperitoneal,
subcutaneous, or
intravenous). Similar resistance to spread was
also seen in irradiated
newborn MA/MyJ mice, suggesting that the
mechanism which blocks virus
spread most likely underlies the
radiation-resistant form of resistance
shown by these mice to
the pathological effects of the virus (data not
shown).
Cell cultures derived from MA/MyJ mice are susceptible to lytic
virus infection.
The resistance of MA/MyJ mice could be accounted
for by a lack of or a reduced level of expression of functional virus
receptors. This possibility was examined by a comparison of the results
of infection of primary kidney cell cultures prepared from baby MA/MyJ and C3H/BiDa mice. Cultures were infected at a low multiplicity (<0.1
PFU/cell), so that multiple cycles of infection would be required to
induce full cytopathic effects. As shown in Fig.
2, cultures from both mice developed
extensive cytopathic changes typical of polyomavirus infection after 1 week. Thus, while kidneys of MA/MyJ mice are largely spared in vivo
(Fig. 1), kidney cells in culture from these mice are readily killed by
the virus. This result demonstrates that at the cellular level, MA/MyJ
mice are capable of expressing functional virus receptors as well as
other factors essential for productive viral infection.

View larger version (154K):
[in this window]
[in a new window]
|
FIG. 2.
Uninfected and infected kidney cultures from baby
C3H/BiDa (A and B, respectively) and MA/MyJ (C and D, respectively)
mice. Infected cultures are shown 7 days postinfection. See text.
|
|
Tests for innate immunity in S, Rr-s, and
Rr-r mice.
Several aspects of innate immunity are
known to affect host resistance to viral infection. Among these, the
production of NK cells is of possible relevance to the Rr-r
phenotype, first because of the known relative resistance of NK cells
to radiation, and second because NK cells are regulated in part by type
1 (antiviral) interferons. To test the possibility that resistance of
MA/MyJ mice may be due to these aspects of innate immunity, levels of
NK activity and antiviral interferons were measured and compared in
young adult mice of each prototype strain. NK activity was measured in
a standard cytotoxic assay with spleen-derived leukocytes and
chromium-labeled YAC-1 target cells (25). No significant
levels of NK activity were seen, and no differences among the three
mouse strains were noted (Fig. 3).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Assay for NK cytotoxic activity. E/T, effector/target
ratios with splenocyte suspensions from normal mouse spleens as
effectors and chromium-51-labelled YAC-1 target cells. Incubations were
overnight at 37°C. Percent cytotoxicity was calculated as described
previously (25).
|
|
Sera from the same mice were tested for their ability to protect L929
cells from infection by vesicular stomatitis virus in
a standard
assay for antiviral interferons (
25). Serum titers
were
found to be uniformly low. Those found for MA/MyJ mice, though
somewhat
higher than those for C57BR/cdJ, were no higher than
those for
susceptible C3H/BiDa mice (Table
2).
Sera of normal mice were also tested in a hemagglutination inhibition
assay with polyomavirus and guinea pig erythrocytes.
The titers were
insignificant or undetectable in all cases (data
not shown). These
results rule out the presence of natural virus
inhibitors in sera of
MA/MyJ mice as well as that of specific
antiviral antibodies which
would have been present if MA/MyJ mice
in our colony were accidentally
infected by and carrying polyomavirus.
The resistance of MA/MyJ mice to
polyomavirus infections thus
does not appear to be due to high levels
of innate immunity or
to preexisting polyomavirus infection with
development of antiviral
humoral
immunity.
Differences in genetic transmission of resistance by
Rr-s and Rr-r mice.
The resistance
of Rr-s mice was previously found to be
recessive in a cross between C57BR/Rr-r cdJ
(Rr-s) and C3H/BiDa (S) (17, 19). In contrast,
resistance conferred by the Rr-r trait is inherited in a
dominant or codominant fashion. The dominance of Rr-r is
evident with variable penetrance, depending on the assay. Under the
conditions of our tests, the Rr-r trait shows incomplete
penetrance in F1 animals, based on protection from tumor
development, but complete penetrance in protecting the host from the
acute lethality of the virulent LID strain.
Following is a comparison of tumor frequencies in neonatally infected
F
1 mice produced in crosses between C3H/BiDa, the common
susceptible parent, and either C57BR/cdJ (R
r-s) or MA/MyJ
(R
r-r), the resistant parent. Newborn F
1
animals were inoculated intraperitoneally
with the A2 strain of
polyomavirus at 2 × 10
5 to 5 × 10
5
PFU/animal. F
1s between C57BR/cdJ and C3H/BiDa were fully
susceptible,
with 95% (45 of 47) of the animals developing multiple
tumors,
with an average latency of 93 days (
19). Less
than 50% (14 of
32) of F
1s whose resistant parent was
MA/MyJ developed tumor(s).
These F
1 animals developed fewer
total tumors and fewer tumor
types than F
1s whose
resistant parent was C57BR/cdJ; no tumors
in skin or thymus and only
rare tumors in bone and kidney were
seen. In addition, tumors developed
after a considerably longer,
200-day latent period. When the virus dose
was reduced, none of
the (MA/MyJ × C3H/BiDa) F
1
animals developed tumors. C57BR/cdJ
× C3H/BiDa F
1
mice, though not tested here, are expected to remain
fully susceptible
to low virus doses, based on the known mechanism
of susceptibility
operating in this cross (
17) and on the fact
that C3H/BiDa
mice are susceptible to extremely low doses of virus
(
5).
In an assay based on the survival of newborn F
1 mice
inoculated with LID, the dominance of the R
r-r trait was
complete. Newborn F
1 animals (<24 h) were inoculated
intraperitoneally with the LID strain of virus at approximately
2 × 10
5 to 5 × 10
5 PFU/animal. Survival
was measured at 30 days. Virtually 100%
(14 of 14) of F
1
mice with the resistant parent MA/MyJ survived
infection by LID. This
result contrasts with 0% survival of F
1s
(0 of 20)
produced by a cross between C57BR/cdJ and C3H/BiDa,
two LID-susceptible
strains.
 |
DISCUSSION |
The resistance of MA/MyJ mice to polyomavirus differs from
that of C57BR/cdJ and other resistant strains which mount
effective anti-polyomavirus tumor immune responses. Indeed,
MA/MyJ mice carry both the MHC type (H-2k) and
an endogenous mouse mammary tumor virus superantigen (Mtv-43 sag, with V
specificity identical to that of Mtv-7 sag
[21]) predictive of a highly susceptible phenotype
based on an inability to mount such antitumor responses
(17). The fact that their resistance cannot be overcome by
immunosuppressive doses of radiation further indicates a
nonimmunological basis.
The Rr-r form of resistance exhibited by MA/MyJ mice
contrasts with the Rr-s form of C57BR/cdJ in several
additional ways. The resistance of MA/MyJ extends in dramatic fashion
to newborns inoculated with the virulent LID strain of virus, which
kills C57BR/cdJ and other Rr-s strains but not MA/MyJ.
Virus replication and spread are sharply curtailed in MA/MyJ compared
with those in C57BR/cdJ mice. In crosses with the highly susceptible
C3H/BiDa strain, MA/MyJ transmits its resistance in a dominant or
codominant manner, while that of C57BR/cdJ is completely recessive.
MA/MyJ is unique among the strains we have examined so far in that it
exhibits all of the above-mentioned properties. However, the CE/J mouse
resembles MA/MyJ in its adult onset Rr-r phenotype, showing
resistance to the induction of tumors following radiation as adults but
limited susceptibility as newborns.
The Rr-r phenotype is based on a nonimmunological mechanism
that blocks dissemination of the virus in vivo. Neither a high level of
NK cells nor a high level of antiviral interferons accounts for this
form of resistance. The failure of the virus to replicate and spread in
vivo does not result from an inability of the host to express virus
receptors, since kidney cultures from baby MA/MyJ mice are fully
susceptible to infection. A simple deficiency of virus receptors in
vivo would also be incompatible with the observed dominance of the
Rr-r phenotype. A limited array of tumors arise in roughly
half of MA/MyJ mice inoculated with LID as newborns, indicating that at least some cell types in these mice bear receptors for the virus and
can be transformed in vivo. These results are consistent with a strong
down-regulation of virus spread which spares the animal from the acute
lethal effects of the virus while allowing enough dissemination for the
induction of some tumors.
Expression in the intact host of some factor(s) that binds and diverts
the virus from infecting target cells or acts intracellularly to
prevent virus release could, in principle, account for the Rr-r phenotype. An efficient apoptotic response of MA/MyJ
mice to viral infection, i.e., one that acts in some way to
override the polyomavirus's antiapoptotic mechanism (4,
20), would also be consistent with the present findings.
Experimental approaches to identify the physiological and molecular
bases of the Rr-r form of polyomavirus resistance are
limited at present due to inability to model the resistance in culture.
However, with the relatively rapid assay LID survival test and the
clear dominance of the Rr-r trait, a genetic approach to
identify the gene(s) involved should be possible.
 |
ACKNOWLEDGMENTS |
This work has been supported by Public Health Service grants
R35-CA44343 and PO1-CA50661.
We acknowledge the expert technical assistance of Sherrie Witt.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Phone: (617) 432-1960. Fax: (617) 277-5291. E-mail:
benjamin{at}warren.med.harvard.edu.
 |
REFERENCES |
| 1.
|
Allison, A. C., and L. W. Law.
1968.
Effects of antilymphocyte serum on virus oncogenisis.
Proc. Soc. Exp. Biol. Med.
127:207-212[Medline].
|
| 2.
|
Bauer, P. H.,
R. T. Bronson,
S. C. Fung,
R. Freund,
T. Stehle,
S. C. Harrison, and T. L. Benjamin.
1995.
Genetic and structural analysis of a virulence determinant in polyomavirus VP1.
J. Virol.
69:7925-7931[Abstract].
|
| 3.
|
Bolen, J. B.,
S. E. Fisher,
K. Chowdhury,
T. C. Shan,
J. E. Williams,
C. J. Dawe, and M. A. Israel.
1985.
A determinant of polyomavirus virulence enhances virus growth in cells of renal origin.
J. Virol.
53:335-339[Abstract/Free Full Text].
|
| 4.
|
Dahl, J.,
A. Jurczak,
L. A. Cheng,
D. C. Baker, and T. L. Benjamin.
1998.
Evidence for a role of phosphatidylinositol 3-kinase activation in blocking of apoptosis by polyoma virus middle T antigen.
J. Virol.
72:3221-3226[Abstract/Free Full Text].
|
| 5.
|
Dawe, C. J.,
R. Freund,
G. Mandel,
K. Ballmer-Hofer,
D. A. Talmage, and T. L. Benjamin.
1987.
Variations in polyoma virus genotype in relation to tumor induction in mice: characterization of wild type strains with widely differing tumor profiles.
Am. J. Pathol.
127:243-261[Abstract].
|
| 6.
|
Dubensky, T. W.,
R. Freund,
C. J. Dawe, and T. L. Benjamin.
1991.
Polyomavirus replication in mice: influences of VP1 type and route of inoculation.
J. Virol.
65:342-349[Abstract/Free Full Text].
|
| 7.
|
Dubensky, T. W.,
F. A. Murphy, and L. P. Villarreal.
1984.
The detection of DNA and RNA virus genomes in the organ systems of whole mice: patterns of mouse organ infection by polyomavirus.
J. Virol.
50:779-783[Abstract/Free Full Text].
|
| 8.
|
Eddy, B. E.
1969.
Polyoma virus, p. 1-114.
In
S. Gard, C. Hallauer, and K. F. Meyer (ed.), Virology monographs, vol. 7. Springer-Verlag, New York, N.Y.
|
| 9.
|
Freund, R.,
A. Calderone,
C. J. Dawe, and T. L. Benjamin.
1990.
Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen.
J. Virol.
65:335-341.
|
| 10.
|
Freund, R.,
C. J. Dawe, and T. L. Benjamin.
1988.
Duplication of noncoding sequences in polyomavirus is required for the development of thymic tumors in mice.
J. Virol.
62:3896-3899[Abstract/Free Full Text].
|
| 11.
|
Freund, R.,
T. Dubensky,
R. Bronson,
R. Sotnikov,
J. Carroll, and T. Benjamin.
1992.
Polyoma tumorigenesis in mice: evidence for dominant resistance and dominant susceptibility genes of the host.
Virology
191:724-731[Medline].
|
| 12.
|
Freund, R.,
R. L. Garcea,
R. Sahli, and T. L. Benjamin.
1991.
A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior.
J. Virol.
65:350-355[Abstract/Free Full Text].
|
| 13.
|
Freund, R.,
A. Sotnikov,
R. T. Bronson, and T. L. Benjamin.
1992.
Changes in frequency, morphology and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene.
Am. J. Pathol.
141:1409-1425[Abstract].
|
| 14.
|
Gross, L. G.
1983.
Oncogenic viruses, 3rd ed.
Pergamon Press, Oxford, England.
|
| 15.
|
Law, L. L.
1966.
Immunologic responsiveness and the induction of experimental neoplasms.
Cancer Res.
26:1121-1132[Abstract/Free Full Text].
|
| 16.
|
Law, L. L., and C. J. Dawe.
1960.
Influence of total body X-irradiation on tumor induction by parotid tumor agent in adult mice.
Proc. Soc. Exp. Biol. Med.
105:414-419.
|
| 17.
|
Lukacher, A. E.,
Y. Ma,
J. P. Carroll,
S. R. Abromson-Leeman,
J. C. Laning,
M. E. Dorf, and T. L. Benjamin.
1995.
Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.
J. Exp. Med.
18:1683-1692.
|
| 18.
|
Lukacher, A. E., and C. S. Wilson.
1998.
Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
J. Immunol.
160:1724-1734[Abstract/Free Full Text].
|
| 19.
|
Lukacher, A. L.,
R. Freund,
J. P. Carroll,
R. T. Bronson, and T. L. Benjamin.
1993.
Pyvs: a dominantly acting gene in C3H/BiDa mice conferring susceptibility to tumor induction by polyoma virus.
Virology
196:241-248[Medline].
|
| 20.
|
Meili, R.,
P. Cron,
B. A. Hemmings, and K. Ballmer-Hofer.
1998.
Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent mechanism.
Oncogene
16:903-907[Medline].
|
| 21.
|
Rudy, C. K.,
E. Kraus,
E. Palmer, and B. T. Huber.
1992.
Mls-l-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7.
J. Exp. Med.
175:1613-1621[Abstract/Free Full Text].
|
| 22.
|
Stehle, T., and S. C. Harrison.
1996.
Crystal structures of polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments.
Structure
4:183-194[Medline].
|
| 23.
|
Stehle, T.,
Y. Yan,
T. L. Benjamin, and S. C. Harrison.
1994.
The structure of murine polyomavirus complexed with an oligosaccharide receptor fragment.
Nature
369:160-163[Medline].
|
| 24.
|
Ting, R. C., and L. W. Law.
1965.
The role of thymus in transplantation resistance induced by polyoma virus.
J. Natl. Cancer Inst.
34:521-527.
|
| 25.
|
Welsh, R. M.,
H. Yang, and J. F. Bukowski.
1988.
The role of interferon in the regulation of virus infections by cytotoxic lymphocytes.
Bioessays
8:10-13[Medline].
|
Journal of Virology, February 1999, p. 1213-1218, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Velupillai, P., Carroll, J. P., Benjamin, T. L.
(2002). Susceptibility to Polyomavirus-Induced Tumors in Inbred Mice: Role of Innate Immune Responses. J. Virol.
76: 9657-9663
[Abstract]
[Full Text]
-
Gottlieb, K. A., Villarreal, L. P.
(2001). Natural Biology of Polyomavirus Middle T Antigen. Microbiol. Mol. Biol. Rev.
65: 288-318
[Abstract]
[Full Text]
-
Sanjuan, N., Porrás, A., Otero, J., Perazzo, S.
(2001). Expression of Major Capsid Protein VP-1 in the Absence of Viral Particles in Thymomas Induced by Murine Polyomavirus. J. Virol.
75: 2891-2899
[Abstract]
[Full Text]
-
Wirth, J. J., Chen, L., Fluck, M. M.
(2000). Systemic Polyomavirus Genome Increase and Dissemination of Capsid-Defective Genomes in Mammary Gland Tumor-Bearing Mice. J. Virol.
74: 6975-6983
[Abstract]
[Full Text]
-
Velupillai, P., Yoshizawa, I., Dey, D. C., Nahill, S. R., Carroll, J. P., Bronson, R. T., Benjamin, T. L.
(1999). Wild-Derived Inbred Mice Have a Novel Basis of Susceptibility to Polyomavirus-Induced Tumors. J. Virol.
73: 10079-10085
[Abstract]
[Full Text]
-
Bauer, P. H., Cui, C., Stehle, T., Harrison, S. C., DeCaprio, J. A., Benjamin, T. L.
(1999). Discrimination between Sialic Acid-Containing Receptors and Pseudoreceptors Regulates Polyomavirus Spread in the Mouse. J. Virol.
73: 5826-5832
[Abstract]
[Full Text]